In addition, it is significantly increased in vascular lesions and the kidneys of patients with hyperglycemia and/or hyperlipidemia, suggesting the dysregulation of CD36 levels in obesity and related metabolic dysfunction [38]. Here, CD36 is linked to obesity disorder.